1. Weiss SW, Goldblum JR, Enzinger FM. Enzinger and Weiss's soft tissue tumors. 2001. 4th ed. St. Louis: Mosby;605–607.
2. Argenyi ZB, Piette WW, Goeken JA. Cutaneous angiomyolipoma. A light-microscopic, immunohistochemical, and electron-microscopic study. Am J Dermatopathol. 1991. 13:497–502.
3. Makino E, Yamada J, Tada J, Arata J, Iwatsuki K. Cutaneous angiolipoleiomyoma. J Am Acad Dermatol. 2006. 54:167–171.
Article
4. Beer TW. Cutaneous angiomyolipomas are HMB45 negative, not associated with tuberous sclerosis, and should be considered as angioleiomyomas with fat. Am J Dermatopathol. 2005. 27:418–421.
Article
5. Fitzpatrick JE, Mellette JR Jr, Hwang RJ, Golitz LE, Zaim MT, Clemons D. Cutaneous angiolipoleiomyoma. J Am Acad Dermatol. 1990. 23:1093–1098.
Article
6. Mehregan DA, Mehregan DR, Mehregan AH. Angiomyolipoma. J Am Acad Dermatol. 1992. 27:331–333.
Article
7. Rodriguez-Fernandez A, Caro-Mancilla A. Cutaneous angiomyolipoma with pleomorphic changes. J Am Acad Dermatol. 1993. 29:115–116.
Article
8. Tamura A, Ishikawa O, Miyachi Y. Subgaleal angiomyolipoma. J Dermatol. 1994. 21:514–517.
Article
9. Val-Bernal JF, Mira C. Cutaneous angiomyolipoma. J Cutan Pathol. 1996. 23:364–368.
Article
10. Buyukbabani N, Tetikkurt S, Ozturk AS. Cutaneous angiomyolipoma: report of two cases with emphasis on HMB-45 utility. J Eur Acad Dermatol Venereol. 1998. 11:151–154.
Article
11. Obata C, Murakami Y, Furue M, Kiryu H. Cutaneous angiomyolipoma. Dermatology. 2001. 203:268–270.
Article
12. Debloom JR, Friedrichs A, Swick BL, Whitaker DC. Management of cutaneous angiomyolipoma and its association with tuberous sclerosis. J Dermatol. 2006. 33:783–786.
Article
13. Roma AA, Magi-Galluzzi C, Zhou M. Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Arch Pathol Lab Med. 2007. 131:122–125.
Article
14. Blute ML, Malek RS, Segura JW. Angiomyolipoma: clinical metamorphosis and concepts for management. J Urol. 1988. 139:20–24.
Article